Rohit Soans, MD, Medical Director of Bariatric Surgery at Temple University Hospital and Assistant Professor of Surgery at the Lewis Katz School of Medicine at Temple University, provided insight to the Philadelphia Inquirer about a clinical trial that is testing whether killing cells on the inner surface of the duodenum (the first part of the small intestine past the stomach) can lead to better control of blood sugar in those with type 2 diabetes. The outpatient endoscopic procedure is called duodenal mucosal resurfacing, and early results show reduced A1C, reduced need for insulin and reduced liver fat. Dr. Soans is not involved in the study.
Temple Faculty Physicians is experiencing technical issues with phone lines. If you are experiencing an emergency, please visit your nearest emergency room. If you would like to schedule an appointment with your provider or have general questions or requests, please contact us by using myTempleHealth.
myTempleHealth
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH